Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
Peter R. Galle(Johannes Gutenberg University Mainz), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), Masatoshi Kudo(Kindai University), Shukui Qin(81th Hospital of PLA), Stephen L. Chan(Chinese University of Hong Kong), Sudhakar Chintharlapalli(Pfizer (United States)), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Paolo Abada(Eli Lilly (United States)), William R. Schelman, Morris Sherman(University Health Network), Friedrich Foerster(Johannes Gutenberg University Mainz)
Cited by 591
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k